Experiment study on antineoplastic effect of cantharidin and norcantharidin for bladder squamous cell carcinoma

沈海山,宋志强,李胜文,吴建臣,张卫东,李强,李世海,聂义鑫
DOI: https://doi.org/10.13201/j.issn.1001-1420.2014.07.019
2014-01-01
Journal of Clinical Urology
Abstract:Objective:Cantharidin(CA)is recently used as anti-tumor natural medicine in many cancers including bladder carcinoma,but the mechanisms are poorly understood.This study is aimed to explore the inhibit effects of CA and its derivative-norcantharidin(NCTD)on bladder squamous cell carcinoma(BSCC)in vitro.Method:Cultured BSCCs were treated with CA or NCTD at different concentrations for 12h,24h,36h,48h and 60h,then cell viability was measured by MTT assay.After treated by CA and NCTD at optimized concentrations,BSCC cellular morphological changes were also investigated by using Laser Scanning Confocal Microscope(LSCM)and Electron Microscope.Result:Both CA and NCTD were able to decrease BSCC viability in time dependent and dose dependent manners;the maximum effect dose was 60μmol/L.When cells were treated with CA or NCTD at 60μmol/L for 24hor 36h,apoptosis was induced in BSCC,more apoptotic bodies were founded in CA group.Conclusion:Our findings provide new details concerning the toxicity of CA and NCTD towards BSCC.Both CA and NCTD induced apoptosis in BSCC,CA showed more cytotoxic effect than to NCTD.CA will be helpful to medicine therapy of BSCC.This knowledge provides a basis for chemotherapeutic development of bladder carcinoma.
What problem does this paper attempt to address?